 | • レポートコード：QYR2104Z5022 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、157ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、網膜静脈閉塞症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分枝網膜動脈閉塞、網膜中心静脈閉塞症）、用途別市場規模（病院・診療所、研究・学術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・網膜静脈閉塞症の市場動向 ・企業の競争状況、市場シェア ・網膜静脈閉塞症の種類別市場規模（分枝網膜動脈閉塞、網膜中心静脈閉塞症） ・網膜静脈閉塞症の用途別市場規模（病院・診療所、研究・学術、その他） ・網膜静脈閉塞症の北米市場規模2016-2027（アメリカ、カナダ） ・網膜静脈閉塞症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜静脈閉塞症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜静脈閉塞症の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜静脈閉塞症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Bayer、Bristol-Myers Squibb、Regeneron Pharmaceuticals、Ellex Medical Lasers、GlaxoSmithKline Plc.、IRIDEX Corporation、Novartis、Quantel Medical Inc.、Topcon Medical Systems, Inc.、ZEISS、Lumenis、Sanofi Aventis、Bausch Health、Alimera Sciences、Fovea Pharmaceuticals SA、Icon Biosciences、Suzuken Co.Ltd.、Genentech, Inc.、Ranbaxy Pharmaceuticals、Johnson & Johnson Services, Inc.、Teva Pharmaceutical, Pfizer Inc.、Astrazeneca、Aerpio Therapeutics Inc.、Annexin Pharmaceuticals AB） ・結論 |
Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide.
The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.
Market Analysis and Insights: Global Retinal Vein Occlusion Market
The global Retinal Vein Occlusion market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Vein Occlusion market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Vein Occlusion market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Vein Occlusion market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Vein Occlusion market.
Global Retinal Vein Occlusion Scope and Market Size
Retinal Vein Occlusion market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Vein Occlusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Branch Retinal Artery Occlusion
Central Retinal Vein Occlusion
Segment by Application
Hospitals and Clinics
Research and Academics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Bayer
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Ellex Medical Lasers
GlaxoSmithKline Plc.
IRIDEX Corporation
Novartis
Quantel Medical Inc.
Regeneron Pharmaceuticals
Ellex Medical Lasers
Lumenis
Sanofi Aventis
Bausch Health
Alimera Sciences
Fovea Pharmaceuticals SA
Icon Biosciences
Suzuken Co.Ltd.
Genentech, Inc.
Ranbaxy Pharmaceuticals
Johnson & Johnson Services, Inc.
Teva Pharmaceutical, Pfizer Inc.
Astrazeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Vein Occlusion Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Branch Retinal Artery Occlusion
1.2.3 Central Retinal Vein Occlusion
1.3 Market by Application
1.3.1 Global Retinal Vein Occlusion Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Research and Academics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Vein Occlusion Market Perspective (2016-2027)
2.2 Retinal Vein Occlusion Growth Trends by Regions
2.2.1 Retinal Vein Occlusion Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Vein Occlusion Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Vein Occlusion Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Vein Occlusion Industry Dynamic
2.3.1 Retinal Vein Occlusion Market Trends
2.3.2 Retinal Vein Occlusion Market Drivers
2.3.3 Retinal Vein Occlusion Market Challenges
2.3.4 Retinal Vein Occlusion Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Vein Occlusion Players by Revenue
3.1.1 Global Top Retinal Vein Occlusion Players by Revenue (2016-2021)
3.1.2 Global Retinal Vein Occlusion Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Vein Occlusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Vein Occlusion Revenue
3.4 Global Retinal Vein Occlusion Market Concentration Ratio
3.4.1 Global Retinal Vein Occlusion Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Vein Occlusion Revenue in 2020
3.5 Retinal Vein Occlusion Key Players Head office and Area Served
3.6 Key Players Retinal Vein Occlusion Product Solution and Service
3.7 Date of Enter into Retinal Vein Occlusion Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Vein Occlusion Breakdown Data by Type
4.1 Global Retinal Vein Occlusion Historic Market Size by Type (2016-2021)
4.2 Global Retinal Vein Occlusion Forecasted Market Size by Type (2022-2027)
5 Retinal Vein Occlusion Breakdown Data by Application
5.1 Global Retinal Vein Occlusion Historic Market Size by Application (2016-2021)
5.2 Global Retinal Vein Occlusion Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retinal Vein Occlusion Market Size (2016-2027)
6.2 North America Retinal Vein Occlusion Market Size by Type
6.2.1 North America Retinal Vein Occlusion Market Size by Type (2016-2021)
6.2.2 North America Retinal Vein Occlusion Market Size by Type (2022-2027)
6.2.3 North America Retinal Vein Occlusion Market Size by Type (2016-2027)
6.3 North America Retinal Vein Occlusion Market Size by Application
6.3.1 North America Retinal Vein Occlusion Market Size by Application (2016-2021)
6.3.2 North America Retinal Vein Occlusion Market Size by Application (2022-2027)
6.3.3 North America Retinal Vein Occlusion Market Size by Application (2016-2027)
6.4 North America Retinal Vein Occlusion Market Size by Country
6.4.1 North America Retinal Vein Occlusion Market Size by Country (2016-2021)
6.4.2 North America Retinal Vein Occlusion Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Retinal Vein Occlusion Market Size (2016-2027)
7.2 Europe Retinal Vein Occlusion Market Size by Type
7.2.1 Europe Retinal Vein Occlusion Market Size by Type (2016-2021)
7.2.2 Europe Retinal Vein Occlusion Market Size by Type (2022-2027)
7.2.3 Europe Retinal Vein Occlusion Market Size by Type (2016-2027)
7.3 Europe Retinal Vein Occlusion Market Size by Application
7.3.1 Europe Retinal Vein Occlusion Market Size by Application (2016-2021)
7.3.2 Europe Retinal Vein Occlusion Market Size by Application (2022-2027)
7.3.3 Europe Retinal Vein Occlusion Market Size by Application (2016-2027)
7.4 Europe Retinal Vein Occlusion Market Size by Country
7.4.1 Europe Retinal Vein Occlusion Market Size by Country (2016-2021)
7.4.2 Europe Retinal Vein Occlusion Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retinal Vein Occlusion Market Size (2016-2027)
8.2 Asia-Pacific Retinal Vein Occlusion Market Size by Type
8.2.1 Asia-Pacific Retinal Vein Occlusion Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Vein Occlusion Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Vein Occlusion Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Vein Occlusion Market Size by Application
8.3.1 Asia-Pacific Retinal Vein Occlusion Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Vein Occlusion Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Vein Occlusion Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Vein Occlusion Market Size by Region
8.4.1 Asia-Pacific Retinal Vein Occlusion Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Vein Occlusion Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Vein Occlusion Market Size (2016-2027)
9.2 Latin America Retinal Vein Occlusion Market Size by Type
9.2.1 Latin America Retinal Vein Occlusion Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Vein Occlusion Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Vein Occlusion Market Size by Type (2016-2027)
9.3 Latin America Retinal Vein Occlusion Market Size by Application
9.3.1 Latin America Retinal Vein Occlusion Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Vein Occlusion Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Vein Occlusion Market Size by Application (2016-2027)
9.4 Latin America Retinal Vein Occlusion Market Size by Country
9.4.1 Latin America Retinal Vein Occlusion Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Vein Occlusion Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Vein Occlusion Market Size (2016-2027)
10.2 Middle East & Africa Retinal Vein Occlusion Market Size by Type
10.2.1 Middle East & Africa Retinal Vein Occlusion Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Vein Occlusion Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Vein Occlusion Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Vein Occlusion Market Size by Application
10.3.1 Middle East & Africa Retinal Vein Occlusion Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Vein Occlusion Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Vein Occlusion Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Vein Occlusion Market Size by Country
10.4.1 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Vein Occlusion Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Retinal Vein Occlusion Introduction
11.1.4 Allergan Revenue in Retinal Vein Occlusion Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Retinal Vein Occlusion Introduction
11.2.4 Bayer Revenue in Retinal Vein Occlusion Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Retinal Vein Occlusion Introduction
11.3.4 Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Regeneron Pharmaceuticals
11.4.1 Regeneron Pharmaceuticals Company Details
11.4.2 Regeneron Pharmaceuticals Business Overview
11.4.3 Regeneron Pharmaceuticals Retinal Vein Occlusion Introduction
11.4.4 Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2016-2021)
11.4.5 Regeneron Pharmaceuticals Recent Development
11.5 Ellex Medical Lasers
11.5.1 Ellex Medical Lasers Company Details
11.5.2 Ellex Medical Lasers Business Overview
11.5.3 Ellex Medical Lasers Retinal Vein Occlusion Introduction
11.5.4 Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2016-2021)
11.5.5 Ellex Medical Lasers Recent Development
11.6 GlaxoSmithKline Plc.
11.6.1 GlaxoSmithKline Plc. Company Details
11.6.2 GlaxoSmithKline Plc. Business Overview
11.6.3 GlaxoSmithKline Plc. Retinal Vein Occlusion Introduction
11.6.4 GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.6.5 GlaxoSmithKline Plc. Recent Development
11.7 IRIDEX Corporation
11.7.1 IRIDEX Corporation Company Details
11.7.2 IRIDEX Corporation Business Overview
11.7.3 IRIDEX Corporation Retinal Vein Occlusion Introduction
11.7.4 IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2016-2021)
11.7.5 IRIDEX Corporation Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Retinal Vein Occlusion Introduction
11.8.4 Novartis Revenue in Retinal Vein Occlusion Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Quantel Medical Inc.
11.9.1 Quantel Medical Inc. Company Details
11.9.2 Quantel Medical Inc. Business Overview
11.9.3 Quantel Medical Inc. Retinal Vein Occlusion Introduction
11.9.4 Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.9.5 Quantel Medical Inc. Recent Development
11.10 Topcon Medical Systems, Inc.
11.10.1 Topcon Medical Systems, Inc. Company Details
11.10.2 Topcon Medical Systems, Inc. Business Overview
11.10.3 Topcon Medical Systems, Inc. Retinal Vein Occlusion Introduction
11.10.4 Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.10.5 Topcon Medical Systems, Inc. Recent Development
11.11 ZEISS
11.11.1 ZEISS Company Details
11.11.2 ZEISS Business Overview
11.11.3 ZEISS Retinal Vein Occlusion Introduction
11.11.4 ZEISS Revenue in Retinal Vein Occlusion Business (2016-2021)
11.11.5 ZEISS Recent Development
11.12 Lumenis
11.12.1 Lumenis Company Details
11.12.2 Lumenis Business Overview
11.12.3 Lumenis Retinal Vein Occlusion Introduction
11.12.4 Lumenis Revenue in Retinal Vein Occlusion Business (2016-2021)
11.12.5 Lumenis Recent Development
11.13 Sanofi Aventis
11.13.1 Sanofi Aventis Company Details
11.13.2 Sanofi Aventis Business Overview
11.13.3 Sanofi Aventis Retinal Vein Occlusion Introduction
11.13.4 Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2016-2021)
11.13.5 Sanofi Aventis Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Retinal Vein Occlusion Introduction
11.14.4 Bausch Health Revenue in Retinal Vein Occlusion Business (2016-2021)
11.14.5 Bausch Health Recent Development
11.15 Alimera Sciences
11.15.1 Alimera Sciences Company Details
11.15.2 Alimera Sciences Business Overview
11.15.3 Alimera Sciences Retinal Vein Occlusion Introduction
11.15.4 Alimera Sciences Revenue in Retinal Vein Occlusion Business (2016-2021)
11.15.5 Alimera Sciences Recent Development
11.16 Fovea Pharmaceuticals SA
11.16.1 Fovea Pharmaceuticals SA Company Details
11.16.2 Fovea Pharmaceuticals SA Business Overview
11.16.3 Fovea Pharmaceuticals SA Retinal Vein Occlusion Introduction
11.16.4 Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2016-2021)
11.16.5 Fovea Pharmaceuticals SA Recent Development
11.17 Icon Biosciences
11.17.1 Icon Biosciences Company Details
11.17.2 Icon Biosciences Business Overview
11.17.3 Icon Biosciences Retinal Vein Occlusion Introduction
11.17.4 Icon Biosciences Revenue in Retinal Vein Occlusion Business (2016-2021)
11.17.5 Icon Biosciences Recent Development
11.18 Suzuken Co.Ltd.
11.18.1 Suzuken Co.Ltd. Company Details
11.18.2 Suzuken Co.Ltd. Business Overview
11.18.3 Suzuken Co.Ltd. Retinal Vein Occlusion Introduction
11.18.4 Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.18.5 Suzuken Co.Ltd. Recent Development
11.18 Genentech, Inc.
11.25.1 Genentech, Inc. Company Details
11.25.2 Genentech, Inc. Business Overview
11.25.3 Genentech, Inc. Retinal Vein Occlusion Introduction
11.25.4 Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.25.5 Genentech, Inc. Recent Development
11.20 Ranbaxy Pharmaceuticals
11.20.1 Ranbaxy Pharmaceuticals Company Details
11.20.2 Ranbaxy Pharmaceuticals Business Overview
11.20.3 Ranbaxy Pharmaceuticals Retinal Vein Occlusion Introduction
11.20.4 Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2016-2021)
11.20.5 Ranbaxy Pharmaceuticals Recent Development
11.21 Johnson & Johnson Services, Inc.
11.21.1 Johnson & Johnson Services, Inc. Company Details
11.21.2 Johnson & Johnson Services, Inc. Business Overview
11.21.3 Johnson & Johnson Services, Inc. Retinal Vein Occlusion Introduction
11.21.4 Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.21.5 Johnson & Johnson Services, Inc. Recent Development
11.22 Teva Pharmaceutical, Pfizer Inc.
11.22.1 Teva Pharmaceutical, Pfizer Inc. Company Details
11.22.2 Teva Pharmaceutical, Pfizer Inc. Business Overview
11.22.3 Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Introduction
11.22.4 Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.22.5 Teva Pharmaceutical, Pfizer Inc. Recent Development
11.23 Astrazeneca
11.23.1 Astrazeneca Company Details
11.23.2 Astrazeneca Business Overview
11.23.3 Astrazeneca Retinal Vein Occlusion Introduction
11.23.4 Astrazeneca Revenue in Retinal Vein Occlusion Business (2016-2021)
11.23.5 Astrazeneca Recent Development
11.24 Aerpio Therapeutics Inc.
11.24.1 Aerpio Therapeutics Inc. Company Details
11.24.2 Aerpio Therapeutics Inc. Business Overview
11.24.3 Aerpio Therapeutics Inc. Retinal Vein Occlusion Introduction
11.24.4 Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2016-2021)
11.24.5 Aerpio Therapeutics Inc. Recent Development
11.25 Annexin Pharmaceuticals AB
11.25.1 Annexin Pharmaceuticals AB Company Details
11.25.2 Annexin Pharmaceuticals AB Business Overview
11.25.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Introduction
11.25.4 Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2016-2021)
11.25.5 Annexin Pharmaceuticals AB Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retinal Vein Occlusion Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Branch Retinal Artery Occlusion
Table 3. Key Players of Central Retinal Vein Occlusion
Table 4. Global Retinal Vein Occlusion Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Retinal Vein Occlusion Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Retinal Vein Occlusion Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Retinal Vein Occlusion Market Share by Regions (2016-2021)
Table 8. Global Retinal Vein Occlusion Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Retinal Vein Occlusion Market Share by Regions (2022-2027)
Table 10. Retinal Vein Occlusion Market Trends
Table 11. Retinal Vein Occlusion Market Drivers
Table 12. Retinal Vein Occlusion Market Challenges
Table 13. Retinal Vein Occlusion Market Restraints
Table 14. Global Retinal Vein Occlusion Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Retinal Vein Occlusion Market Share by Players (2016-2021)
Table 16. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion as of 2020)
Table 17. Ranking of Global Top Retinal Vein Occlusion Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Retinal Vein Occlusion Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Retinal Vein Occlusion Product Solution and Service
Table 21. Date of Enter into Retinal Vein Occlusion Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Retinal Vein Occlusion Revenue Market Share by Type (2016-2021)
Table 25. Global Retinal Vein Occlusion Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Retinal Vein Occlusion Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Retinal Vein Occlusion Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Retinal Vein Occlusion Revenue Market Share by Application (2016-2021)
Table 29. Global Retinal Vein Occlusion Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Retinal Vein Occlusion Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Retinal Vein Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Retinal Vein Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Retinal Vein Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Retinal Vein Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Retinal Vein Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Retinal Vein Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Retinal Vein Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Retinal Vein Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Retinal Vein Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Retinal Vein Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Retinal Vein Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinal Vein Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinal Vein Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Retinal Vein Occlusion Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Retinal Vein Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Retinal Vein Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Retinal Vein Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Retinal Vein Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Retinal Vein Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Retinal Vein Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Retinal Vein Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinal Vein Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinal Vein Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Retinal Vein Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 61. Allergan Company Details
Table 62. Allergan Business Overview
Table 63. Allergan Retinal Vein Occlusion Product
Table 64. Allergan Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 65. Allergan Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Retinal Vein Occlusion Product
Table 69. Bayer Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Retinal Vein Occlusion Product
Table 74. Bristol-Myers Squibb Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. Regeneron Pharmaceuticals Company Details
Table 77. Regeneron Pharmaceuticals Business Overview
Table 78. Regeneron Pharmaceuticals Retinal Vein Occlusion Product
Table 79. Regeneron Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 80. Regeneron Pharmaceuticals Recent Development
Table 81. Ellex Medical Lasers Company Details
Table 82. Ellex Medical Lasers Business Overview
Table 83. Ellex Medical Lasers Retinal Vein Occlusion Product
Table 84. Ellex Medical Lasers Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 85. Ellex Medical Lasers Recent Development
Table 86. GlaxoSmithKline Plc. Company Details
Table 87. GlaxoSmithKline Plc. Business Overview
Table 88. GlaxoSmithKline Plc. Retinal Vein Occlusion Product
Table 89. GlaxoSmithKline Plc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Plc. Recent Development
Table 91. IRIDEX Corporation Company Details
Table 92. IRIDEX Corporation Business Overview
Table 93. IRIDEX Corporation Retinal Vein Occlusion Product
Table 94. IRIDEX Corporation Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 95. IRIDEX Corporation Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 99. Novartis Recent Development
Table 100. Quantel Medical Inc. Company Details
Table 101. Quantel Medical Inc. Business Overview
Table 102. Quantel Medical Inc. Retinal Vein Occlusion Product
Table 103. Quantel Medical Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 104. Quantel Medical Inc. Recent Development
Table 105. Topcon Medical Systems, Inc. Company Details
Table 106. Topcon Medical Systems, Inc. Business Overview
Table 107. Topcon Medical Systems, Inc. Retinal Vein Occlusion Product
Table 108. Topcon Medical Systems, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 109. Topcon Medical Systems, Inc. Recent Development
Table 110. ZEISS Company Details
Table 111. ZEISS Business Overview
Table 112. ZEISS Retinal Vein Occlusion Product
Table 113. ZEISS Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 114. ZEISS Recent Development
Table 115. Lumenis Company Details
Table 116. Lumenis Business Overview
Table 117. Lumenis Retinal Vein Occlusion Product
Table 118. Lumenis Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 119. Lumenis Recent Development
Table 120. Sanofi Aventis Company Details
Table 121. Sanofi Aventis Business Overview
Table 122. Sanofi Aventis Retinal Vein Occlusion Product
Table 123. Sanofi Aventis Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 124. Sanofi Aventis Recent Development
Table 125. Bausch Health Company Details
Table 126. Bausch Health Business Overview
Table 127. Bausch Health Retinal Vein Occlusion Product
Table 128. Bausch Health Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 129. Bausch Health Recent Development
Table 130. Alimera Sciences Company Details
Table 131. Alimera Sciences Business Overview
Table 132. Alimera Sciences Retinal Vein Occlusion Product
Table 133. Alimera Sciences Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 134. Alimera Sciences Recent Development
Table 135. Fovea Pharmaceuticals SA Company Details
Table 136. Fovea Pharmaceuticals SA Business Overview
Table 137. Fovea Pharmaceuticals SA Retinal Vein Occlusion Product
Table 138. Fovea Pharmaceuticals SA Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 139. Fovea Pharmaceuticals SA Recent Development
Table 140. Icon Biosciences Company Details
Table 141. Icon Biosciences Business Overview
Table 142. Icon Biosciences Retinal Vein Occlusion Product
Table 143. Icon Biosciences Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 144. Icon Biosciences Recent Development
Table 145. Suzuken Co.Ltd. Company Details
Table 146. Suzuken Co.Ltd. Business Overview
Table 147. Suzuken Co.Ltd. Retinal Vein Occlusion Product
Table 148. Suzuken Co.Ltd. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 149. Suzuken Co.Ltd. Recent Development
Table 150. Genentech, Inc. Company Details
Table 151. Genentech, Inc. Business Overview
Table 152. Genentech, Inc. Retinal Vein Occlusion Product
Table 153. Genentech, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 154. Genentech, Inc. Recent Development
Table 155. Ranbaxy Pharmaceuticals Company Details
Table 156. Ranbaxy Pharmaceuticals Business Overview
Table 157. Ranbaxy Pharmaceuticals Retinal Vein Occlusion Product
Table 158. Ranbaxy Pharmaceuticals Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 159. Ranbaxy Pharmaceuticals Recent Development
Table 160. Johnson & Johnson Services, Inc. Company Details
Table 161. Johnson & Johnson Services, Inc. Business Overview
Table 162. Johnson & Johnson Services, Inc. Retinal Vein Occlusion Product
Table 163. Johnson & Johnson Services, Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 164. Johnson & Johnson Services, Inc. Recent Development
Table 165. Teva Pharmaceutical, Pfizer Inc. Company Details
Table 166. Teva Pharmaceutical, Pfizer Inc. Business Overview
Table 167. Teva Pharmaceutical, Pfizer Inc. Retinal Vein Occlusion Product
Table 168. Teva Pharmaceutical, Pfizer Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 169. Teva Pharmaceutical, Pfizer Inc. Recent Development
Table 170. Astrazeneca Company Details
Table 171. Astrazeneca Business Overview
Table 172. Astrazeneca Retinal Vein Occlusion Product
Table 173. Astrazeneca Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 174. Astrazeneca Recent Development
Table 175. Aerpio Therapeutics Inc. Company Details
Table 176. Aerpio Therapeutics Inc. Business Overview
Table 177. Aerpio Therapeutics Inc. Retinal Vein OcclusionProduct
Table 178. Aerpio Therapeutics Inc. Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 179. Aerpio Therapeutics Inc. Recent Development
Table 180. Annexin Pharmaceuticals AB Company Details
Table 181. Annexin Pharmaceuticals AB Business Overview
Table 182. Annexin Pharmaceuticals AB Retinal Vein Occlusion Product
Table 183. Annexin Pharmaceuticals AB Revenue in Retinal Vein Occlusion Business (2016-2021) & (US$ Million)
Table 184. Annexin Pharmaceuticals AB Recent Development
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Vein Occlusion Market Share by Type: 2020 VS 2027
Figure 2. Branch Retinal Artery Occlusion Features
Figure 3. Central Retinal Vein Occlusion Features
Figure 4. Global Retinal Vein Occlusion Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Research and Academics Case Studies
Figure 7. Others Case Studies
Figure 8. Retinal Vein Occlusion Report Years Considered
Figure 9. Global Retinal Vein Occlusion Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Retinal Vein Occlusion Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Retinal Vein Occlusion Market Share by Regions: 2020 VS 2027
Figure 12. Global Retinal Vein Occlusion Market Share by Regions (2022-2027)
Figure 13. Global Retinal Vein Occlusion Market Share by Players in 2020
Figure 14. Global Top Retinal Vein Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vein Occlusion as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Retinal Vein Occlusion Revenue in 2020
Figure 16. Global Retinal Vein Occlusion Revenue Market Share by Type (2016-2021)
Figure 17. Global Retinal Vein Occlusion Revenue Market Share by Type (2022-2027)
Figure 18. North America Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Retinal Vein Occlusion Market Share by Type (2016-2027)
Figure 20. North America Retinal Vein Occlusion Market Share by Application (2016-2027)
Figure 21. North America Retinal Vein Occlusion Market Share by Country (2016-2027)
Figure 22. United States Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Retinal Vein Occlusion Market Share by Type (2016-2027)
Figure 26. Europe Retinal Vein Occlusion Market Share by Application (2016-2027)
Figure 27. Europe Retinal Vein Occlusion Market Share by Country (2016-2027)
Figure 28. Germany Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Retinal Vein Occlusion Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Retinal Vein Occlusion Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Retinal Vein Occlusion Market Share by Region (2016-2027)
Figure 38. China Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Retinal Vein Occlusion Market Share by Type (2016-2027)
Figure 46. Latin America Retinal Vein Occlusion Market Share by Application (2016-2027)
Figure 47. Latin America Retinal Vein Occlusion Market Share by Country (2016-2027)
Figure 48. Mexico Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Retinal Vein Occlusion Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Retinal Vein Occlusion Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Retinal Vein Occlusion Market Share by Country (2016-2027)
Figure 54. Turkey Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Retinal Vein Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Allergan Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 61. Ellex Medical Lasers Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 62. GlaxoSmithKline Plc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 63. IRIDEX Corporation Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 65. Quantel Medical Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 66. Topcon Medical Systems, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 67. ZEISS Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 68. Lumenis Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 69. Sanofi Aventis Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 70. Bausch Health Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 71. Alimera Sciences Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 72. Fovea Pharmaceuticals SA Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 73. Icon Biosciences Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 74. Suzuken Co.Ltd. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 75. Genentech, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 76. Ranbaxy Pharmaceuticals Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 77. Johnson & Johnson Services, Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 78. Teva Pharmaceutical, Pfizer Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 79. Astrazeneca Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 80. Aerpio Therapeutics Inc. Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 81. Annexin Pharmaceuticals AB Revenue Growth Rate in Retinal Vein Occlusion Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界の網膜静脈閉塞症治療薬市場規模・現状・予測（2021年-2027年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…- 世界の網膜静脈閉塞症市場規模・現状・予測（2021年-2027年） Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in sur…
- 世界の網膜血管閉塞市場規模・現状・予測（2021年-2027年） Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot. The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and …
- 世界の黄斑変性症（AMD）・その他網膜疾患市場規模・現状・予測（2021年-2027年） Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands. Market Analysis and Insights: Global…
- 世界の網膜剥離市場規模・現状・予測（2021年-2027年） Retinal detachment occurs when the light-sensitive membrane (retina) in the back of the eye separates from its supporting layers. Most of the retinal detachments occurs due to retinal break, tear or hole. Retinal detachment can cause partial or total blindness, depending upon how much of the retina …